DEXTROSE INJECTION USP

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: b04d9df4fb9dd145
Drug Approval Canada Name: DEXTROSE INJECTION USP
Product Name: DEXTROSE INJECTION USP
Status: Marketed
Status Date: 2020-08-18
Original Market Date: 2020-08-18
Din: 02468514
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Ethical
Ahfs: 40:20.00
Atc Original: B05BA03 CARBOHYDRATES
Atc Name: b 05 ba 03
Aig Number: 0102181001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

DEXTROSE

500 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b04d9df4fb9dd145

Type

Standard